Brokerages Anticipate Plexus Corp. (NASDAQ:PLXS) Will Post Quarterly Sales of $800.15 Million

Last updated on Thursday, July 22, 2021 | 2021 MarketBeat

Equities analysts expect that Plexus Corp. (NASDAQ:PLXS) will report $800.15 million in sales for the current quarter, Zacks reports. Three analysts have issued estimates for Plexus' earnings, with estimates ranging from $795.01 million to $806.40 million. Plexus posted sales of $857.39 million during the same quarter last year, which suggests a negative year over year growth rate of 6.7%. The business is scheduled to issue its next earnings results on Wednesday, July 21st.

According to Zacks, analysts expect that Plexus will report full-year sales of $3.38 billion for the current fiscal year, with estimates ranging from $3.37 billion to $3.39 billion. For the next financial year, analysts expect that the firm will report sales of $3.76 billion, with estimates ranging from $3.66 billion to $3.91 billion. Zacks' sales averages are an average based on a survey of analysts that follow Plexus.

Plexus (NASDAQ:PLXS) last released its quarterly earnings data on Tuesday, April 20th. The technology company reported $1.49 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.25 by $0.24. Plexus had a net margin of 4.35% and a return on equity of 15.55%. The firm had revenue of $881.00 million for the quarter, compared to the consensus estimate of $879.88 million. During the same quarter in the prior year, the company posted $0.61 earnings per share. The business's revenue was up 14.9% on a year-over-year basis.

Several analysts have recently commented on PLXS shares. Loop Capital increased their target price on shares of Plexus from $100.00 to $105.00 and gave the company a "buy" rating in a report on Friday, June 11th. Needham & Company LLC raised their price objective on shares of Plexus from $102.00 to $110.00 and gave the company a "buy" rating in a research report on Tuesday, May 25th. Sidoti upgraded shares of Plexus from a "neutral" rating to a "buy" rating and set a $110.00 price objective for the company in a research report on Tuesday, June 22nd. Raymond James set a $85.73 price objective on shares of Plexus and gave the company a "hold" rating in a research report on Monday. Finally, Zacks Investment Research raised shares of Plexus from a "hold" rating to a "buy" rating and set a $98.00 target price on the stock in a research note on Monday, April 26th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. The stock currently has an average rating of "Buy" and a consensus target price of $95.25.

In other news, CEO Todd P. Kelsey sold 2,500 shares of the firm's stock in a transaction that occurred on Monday, May 10th. The shares were sold at an average price of $96.00, for a total value of $240,000.00. Following the transaction, the chief executive officer now owns 91,657 shares in the company, valued at $8,799,072. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Ronnie Darroch sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, April 26th. The stock was sold at an average price of $94.17, for a total transaction of $94,170.00. Following the completion of the transaction, the vice president now owns 5,591 shares in the company, valued at approximately $526,504.47. The disclosure for this sale can be found here. Insiders have sold 11,076 shares of company stock worth $1,045,755 over the last three months. Insiders own 2.38% of the company's stock.

Several institutional investors have recently modified their holdings of PLXS. State of Alaska Department of Revenue boosted its holdings in Plexus by 1.4% in the second quarter. State of Alaska Department of Revenue now owns 19,779 shares of the technology company's stock valued at $1,807,000 after acquiring an additional 268 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in Plexus in the first quarter valued at $85,000. Earnest Partners LLC boosted its holdings in Plexus by 9.2% in the first quarter. Earnest Partners LLC now owns 1,448,995 shares of the technology company's stock valued at $133,076,000 after acquiring an additional 122,213 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in Plexus by 1.5% in the first quarter. Oppenheimer Asset Management Inc. now owns 16,652 shares of the technology company's stock valued at $1,529,000 after acquiring an additional 246 shares in the last quarter. Finally, Millennium Management LLC bought a new stake in Plexus in the first quarter valued at $1,057,000. Hedge funds and other institutional investors own 92.56% of the company's stock.

PLXS opened at $87.58 on Thursday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.04 and a current ratio of 1.88. The business's fifty day simple moving average is $92.79. Plexus has a 1-year low of $64.35 and a 1-year high of $101.17. The firm has a market capitalization of $2.50 billion, a P/E ratio of 17.14 and a beta of 1.20.

About Plexus

Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Article: Trading Stocks - What are percentage gainers?

Get a free copy of the Zacks research report on Plexus (PLXS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in Plexus right now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.